Cargando…
Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
Lung cancers remain one of the most common and deadly cancers in the world today (12.5% of newly diagnosed cancers) despite current advances in chemo- and radiation therapies. Often, by the time these tumors are diagnosed, they have already metastasized. These tumors demonstrate the classic hallmark...
Autores principales: | Jadus, Martin R., Natividad, Josephine, Mai, Anthony, Ouyang, Yi, Lambrecht, Nils, Szabo, Sandor, Ge, Lisheng, Hoa, Neil, Dacosta-Iyer, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414063/ https://www.ncbi.nlm.nih.gov/pubmed/22899945 http://dx.doi.org/10.1155/2012/160724 |
Ejemplares similares
-
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
por: Aref, Ahmed M, et al.
Publicado: (2014) -
Changes in tumor-antigen expression profile as human small-cell lung cancers progress
por: Ge, Li-Sheng, et al.
Publicado: (2015) -
Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions
por: Ge, Lisheng, et al.
Publicado: (2010) -
Nutrient Availability Alters the Effect of Autophagy on Sulindac Sulfide-Induced Colon Cancer Cell Apoptosis
por: Chiou, Shiun-Kwei, et al.
Publicado: (2012) -
The Classics of Immunology
por: Smith, Kendall A
Publicado: (2005)